Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-08

Clinical Trial Update: A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy [Phase 3]

View source ↗

Summary

Phase 3 double-blind trial comparing zonisamide with carbamazepine as monotherapy in newly diagnosed partial epilepsy; the study assesses efficacy and safety wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)
  • Zonegran (zonisamide)

Snippet

Sponsor: Eisai Inc. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2013-02-08